Therapy with canakinumab for adult-onset still's disease
Still's disease in children (systemic-onset juvenile idiopathic arthritis, SoJIA) and in adults (adult-onset Still's disease) are considered as non-familial systemic autoinflammatory diseases of unknown etiology driven by similar immunopathogenetic mechanisms. The adult-onset Still's...
Saved in:
| Main Author: | E. L. Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2019-04-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2688 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A clinical case of adult-onset Still's disease resistant to therapy with tumor necrosis factor-alpha inhibitors and interleukin-6 inhibitors
by: R. R. Samigullina, et al.
Published: (2019-03-01) -
Adult Still's disease: New horizons
by: E. L. Nasonov, et al.
Published: (2021-12-01) -
Therapy with canakinumab for gout
by: M. S. Eliseev, et al.
Published: (2019-04-01) -
Biomarkers for adult-onset Still’s disease
by: V. Yu. Myachikova, et al.
Published: (2022-07-01) -
Adult Onset Still's Disease - current state of knowledge
by: Anna Centkowska, et al.
Published: (2025-06-01)